Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-06 02:16:37 - browse：2663

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

This week: A chat with Argenx CEO Tim Van Hauwermeiren, and updates on biotech PIPEs, Madrigal Pharmaceuticals, and Annovis Bio.

The Belgian drugmaker Argenx is preparing for a commercial launch this summer that will expand the use of its IgG-lowering antibody Vyvgart to patients with chronic inflammatory demyelinating polyneuropathy, or CIDP, an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Group opposing PBM reform sets lobbying record

WSS

General Catalyst, Summa Health deal will turn on physician buy

Vertex non

Doctors find melanoma drugs effective against rare brain cancer

FDA approves RSV monoclonal antibody for infants, toddlers

Biden administration opens offers in Medicare drug price negotiations

Sanofi seeks simpler, safer CRISPR sickle cell cure

hotspot

Wikipedia

focus

Supreme Court strikes down use of affirmative action

What we need to know about Arena Bioworks

Heart attack and stroke risk calculators need revising

How dance can help nurses traumatized by Covid

Cancer drug shortages should be causing more outrage

Biden tests positive for Covid

Duchenne breakthrough therapy leaves behind pioneering families

New Ultima Genomics DNA sequencer can read genome for $100

What does generative AI mean for health care? We asked experts

New Ultima Genomics DNA sequencer can read genome for $100

focus

Custom gene therapy hints at new path for rare disease treatments

Startup Neumora takes a novel depression drug to Phase 3

As digital health tech proliferates, a new institute aims to cut through hype

SAMSHA loosens regulations on methadone treatment centers

Novo Nordisk to expand supply of Wegovy for U.S. patients

Group opposing PBM reform sets lobbying record

hotspot

hotspot

knowledge

leisure time